Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.

CONCLUSIONS: Small-spot IMPT improves cord, heart, and lung sparing compared to VMAT and achieves clinically acceptable plan robustness at least for the patients included in this study with motion amplitude less than 11 mm. Our study supports the usage of IMPT to treat some lung cancer patients. PMID: 30328674 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30328674?dopt=Abstract

Source: Journal of Applied Clinical Medical Physics - October 17, 2018 Category: Physics Authors: Liu C, Sio TT, Deng W, Shan J, Daniels TB, Rule WG, Lara PR, Korte SM, Shen J, Ding X, Schild SE, Bues M, Liu W Tags: J Appl Clin Med Phys Source Type: research